3,5-Difluoro-2-methylbenzonitrile | CAS:1003708-74-4

We serve 3,5-Difluoro-2-methylbenzonitrile CAS:1003708-74-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3,5-Difluoro-2-methylbenzonitrile

Chemical Name:3,5-Difluoro-2-methylbenzonitrile
CAS.NO:1003708-74-4
Synonyms:3,5-Difluoro-2-methylbenzonitrile
Molecular Formula:C8H5F2N
Molecular Weight:153.12900
 
Specification:
Appearance:Off-white to white crystalline powder
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis



Contact us for information like 3,5-Difluoro-2-methylbenzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5-Difluoro-2-methylbenzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,5-Difluoro-2-methylbenzonitrile Use and application,3,5-Difluoro-2-methylbenzonitrile technical grade,usp/ep/jp grade.


Related News: Like other countries in Southeast Asia, Indonesia depends heavily on Chinese tourism. On Thursday alone, 10,000 Chinese tourists canceled their trips to Bali, according to one industry association.4-Chloro-1,2-diaminobenzene manufacturer GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”DL-Ethyl 2-bromobutyrate supplier Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.3-Bromo-5-nitropyridine vendor By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.